P1021 (10038): An Open-Label Study to Evaluate the Safety, Tolerance, Antiviral Activity and Pharmacokinetics of Emtricitabine in Combination with Efavirenz and Didanosine in a Once-Daily Regimen in HIV-Infected Antiretroviral-Naïve or Very Limited Antiretroviral-Exposed Pediatric Subjects

Study Status Study Restriction

Participants Off Study and Primary Analysis Completed

United States

Sites where the study was implemented:

CRS ID Site Name City Country
No records returned.

Study contacts:

No records returned.

CTS: IMPAACT Operations Center

Department of Health and Human ServicesNational Institutes of Health

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.